APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hyperimmune Globulin Product

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hyperimmune Globulin Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchHyperimmune Globulin Product Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Hyperimmune Globulin Product Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Hyperimmune Globulin Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hyperimmune Globulin Product Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hyperimmune Globulin Product Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hyperimmune Globulin Product market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hyperimmune Globulin Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hyperimmune Globulin Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hyperimmune Globulin Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hyperimmune Globulin Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hyperimmune Globulin Product include CNBG, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, CBPO, Kedrion, Kamada, Grifols and Emergent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hyperimmune Globulin Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hyperimmune Globulin Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hyperimmune Globulin Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hyperimmune Globulin Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Hyperimmune Globulin Product Segment by Company

CNBG

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

CBPO

Kedrion

Kamada

Grifols

Emergent

CSL Behring

Biotest

ADMA Biologics

Hyperimmune Globulin Product Segment by Type

Varicella-Zoster Immune Globulin

Cytomegalovirus Immune Globulin

Rho(D) Immune Globulin

Rabies Immuneglobulins

Tetanus Toxin Immuneglobulins

Hepatitis B Immuneglobulins

Others

Hyperimmune Globulin Product Segment by Application

Government Institution

Private Sector

Others

Hyperimmune Globulin Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulin Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulin Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulin Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hyperimmune Globulin Product market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hyperimmune Globulin Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hyperimmune Globulin Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hyperimmune Globulin Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hyperimmune Globulin Product Industry Trends Table 2. Hyperimmune Globulin Product Industry Drivers Table 3. Hyperimmune Globulin Product Industry Opportunities and Challenges Table 4. Hyperimmune Globulin Product Industry Restraints Table 5. Global Hyperimmune Globulin Product Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hyperimmune Globulin Product Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hyperimmune Globulin Product Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hyperimmune Globulin Product Sales Market Share by Manufacturers Table 9. Global Hyperimmune Globulin Product Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hyperimmune Globulin Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hyperimmune Globulin Product Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hyperimmune Globulin Product Manufacturers, Product Type & Application Table 13. Global Hyperimmune Globulin Product Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hyperimmune Globulin Product by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Varicella-Zoster Immune Globulin Table 17. Major Manufacturers of Cytomegalovirus Immune Globulin Table 18. Major Manufacturers of Rho(D) Immune Globulin Table 19. Major Manufacturers of Rabies Immuneglobulins Table 20. Major Manufacturers of Tetanus Toxin Immuneglobulins Table 21. Major Manufacturers of Hepatitis B Immuneglobulins Table 22. Major Manufacturers of Others Table 23. Global Hyperimmune Globulin Product Sales by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Hyperimmune Globulin Product Sales by Type (2021-2026) & (k units) Table 25. Global Hyperimmune Globulin Product Sales by Type (2027-2032) & (k units) Table 26. Global Hyperimmune Globulin Product Sales Market Share by Type (2021-2026) Table 27. Global Hyperimmune Globulin Product Sales Market Share by Type (2027-2032) Table 28. Global Hyperimmune Globulin Product Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 29. Global Hyperimmune Globulin Product Revenue by Type (2021-2026) & (k units) Table 30. Global Hyperimmune Globulin Product Revenue by Type (2027-2032) & (k units) Table 31. Global Hyperimmune Globulin Product Revenue Market Share by Type (2021-2026) Table 32. Global Hyperimmune Globulin Product Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Government Institution Table 34. Major Manufacturers of Private Sector Table 35. Major Manufacturers of Others Table 36. Global Hyperimmune Globulin Product Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Hyperimmune Globulin Product Sales by Application (2021-2026) & (k units) Table 38. Global Hyperimmune Globulin Product Sales by Application (2027-2032) & (k units) Table 39. Global Hyperimmune Globulin Product Sales Market Share by Application (2021-2026) Table 40. Global Hyperimmune Globulin Product Sales Market Share by Application (2027-2032) Table 41. Global Hyperimmune Globulin Product Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Hyperimmune Globulin Product Revenue by Application (2021-2026) & (k units) Table 43. Global Hyperimmune Globulin Product Revenue by Application (2027-2032) & (k units) Table 44. Global Hyperimmune Globulin Product Revenue Market Share by Application (2021-2026) Table 45. Global Hyperimmune Globulin Product Revenue Market Share by Application (2027-2032) Table 46. Global Hyperimmune Globulin Product Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Hyperimmune Globulin Product Sales by Region (2021-2026) & (k units) Table 48. Global Hyperimmune Globulin Product Sales Market Share by Region (2021-2026) Table 49. Global Hyperimmune Globulin Product Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Hyperimmune Globulin Product Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Hyperimmune Globulin Product Sales by Country (2021-2026) & (k units) Table 53. North America Hyperimmune Globulin Product Sales by Country (2027-2032) & (k units) Table 54. Europe Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Hyperimmune Globulin Product Sales by Country (2021-2026) & (k units) Table 56. Europe Hyperimmune Globulin Product Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Hyperimmune Globulin Product Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Hyperimmune Globulin Product Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Hyperimmune Globulin Product Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Hyperimmune Globulin Product Sales by Country (2027-2032) & (k units) Table 63. Global Hyperimmune Globulin Product Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Hyperimmune Globulin Product Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Hyperimmune Globulin Product Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Hyperimmune Globulin Product Revenue Market Share by Region (2021-2026) Table 67. Global Hyperimmune Globulin Product Revenue Market Share by Region (2027-2032) Table 68. CNBG Company Information Table 69. CNBG Business Overview Table 70. CNBG Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CNBG Hyperimmune Globulin Product Product Portfolio Table 72. CNBG Recent Development Table 73. Sichuan Yuanda Shuyang Company Information Table 74. Sichuan Yuanda Shuyang Business Overview Table 75. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sichuan Yuanda Shuyang Hyperimmune Globulin Product Product Portfolio Table 77. Sichuan Yuanda Shuyang Recent Development Table 78. Shanghai RAAS Company Information Table 79. Shanghai RAAS Business Overview Table 80. Shanghai RAAS Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai RAAS Hyperimmune Globulin Product Product Portfolio Table 82. Shanghai RAAS Recent Development Table 83. Hualan Bio Company Information Table 84. Hualan Bio Business Overview Table 85. Hualan Bio Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hualan Bio Hyperimmune Globulin Product Product Portfolio Table 87. Hualan Bio Recent Development Table 88. CBPO Company Information Table 89. CBPO Business Overview Table 90. CBPO Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. CBPO Hyperimmune Globulin Product Product Portfolio Table 92. CBPO Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Kedrion Hyperimmune Globulin Product Product Portfolio Table 97. Kedrion Recent Development Table 98. Kamada Company Information Table 99. Kamada Business Overview Table 100. Kamada Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Kamada Hyperimmune Globulin Product Product Portfolio Table 102. Kamada Recent Development Table 103. Grifols Company Information Table 104. Grifols Business Overview Table 105. Grifols Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Grifols Hyperimmune Globulin Product Product Portfolio Table 107. Grifols Recent Development Table 108. Emergent Company Information Table 109. Emergent Business Overview Table 110. Emergent Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Emergent Hyperimmune Globulin Product Product Portfolio Table 112. Emergent Recent Development Table 113. CSL Behring Company Information Table 114. CSL Behring Business Overview Table 115. CSL Behring Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. CSL Behring Hyperimmune Globulin Product Product Portfolio Table 117. CSL Behring Recent Development Table 118. Biotest Company Information Table 119. Biotest Business Overview Table 120. Biotest Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Biotest Hyperimmune Globulin Product Product Portfolio Table 122. Biotest Recent Development Table 123. ADMA Biologics Company Information Table 124. ADMA Biologics Business Overview Table 125. ADMA Biologics Hyperimmune Globulin Product Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. ADMA Biologics Hyperimmune Globulin Product Product Portfolio Table 127. ADMA Biologics Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Hyperimmune Globulin Product Distributors List Table 131. Hyperimmune Globulin Product Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Hyperimmune Globulin Product Product Image Figure 2. Global Hyperimmune Globulin Product Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyperimmune Globulin Product Market Size (2021-2032) & (US$ Million) Figure 4. Global Hyperimmune Globulin Product Sales (2021-2032) & (k units) Figure 5. Global Hyperimmune Globulin Product Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hyperimmune Globulin Product Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Varicella-Zoster Immune Globulin Image Figure 9. Cytomegalovirus Immune Globulin Image Figure 10. Rho(D) Immune Globulin Image Figure 11. Rabies Immuneglobulins Image Figure 12. Tetanus Toxin Immuneglobulins Image Figure 13. Hepatitis B Immuneglobulins Image Figure 14. Others Image Figure 15. Global Hyperimmune Globulin Product Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Hyperimmune Globulin Product Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Hyperimmune Globulin Product Sales Market Share by Type (2021-2032) Figure 18. Global Hyperimmune Globulin Product Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Hyperimmune Globulin Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hyperimmune Globulin Product Revenue Market Share by Type (2021-2032) Figure 21. Government Institution Image Figure 22. Private Sector Image Figure 23. Others Image Figure 24. Global Hyperimmune Globulin Product Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Hyperimmune Globulin Product Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hyperimmune Globulin Product Sales Market Share by Application (2021-2032) Figure 27. Global Hyperimmune Globulin Product Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Hyperimmune Globulin Product Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Hyperimmune Globulin Product Revenue Market Share by Application (2021-2032) Figure 30. North America Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Hyperimmune Globulin Product Sales Market Share by Country (2021-2032) Figure 32. U.S. Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Hyperimmune Globulin Product Sales Market Share by Country (2021-2032) Figure 37. Germany Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Hyperimmune Globulin Product Sales Market Share by Country (2021-2032) Figure 44. China Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Hyperimmune Globulin Product Sales Market Share by Country (2021-2032) Figure 52. Brazil Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Hyperimmune Globulin Product Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Hyperimmune Globulin Product Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Hyperimmune Globulin Product Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Hyperimmune Globulin Product Revenue (2021-2032) & (US$ Million) Figure 63. North America Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Hyperimmune Globulin Product Revenue (2021-2032) & (US$ Million) Figure 65. Europe Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Hyperimmune Globulin Product Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Hyperimmune Globulin Product Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Hyperimmune Globulin Product Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Hyperimmune Globulin Product Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Varicella-Zoster Immune Globulin
  • Cytomegalovirus Immune Globulin
  • Rho(D) Immune Globulin
  • Rabies Immuneglobulins
  • Tetanus Toxin Immuneglobulins
  • Hepatitis B Immuneglobulins
  • Others
Applications
  • Government Institution
  • Private Sector
  • Others
Companies covered
  • CNBG
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • CBPO
  • Kedrion
  • Kamada
  • Grifols
  • Emergent
  • CSL Behring
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hyperimmune Globulin Product Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hyperimmune Globulin Product Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hyperimmune Globulin Product Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hyperimmune Globulin Product Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hyperimmune Globulin Product Market Dynamics
  1. 2.1 Hyperimmune Globulin Product Industry Trends
  2. 2.2 Hyperimmune Globulin Product Industry Drivers
  3. 2.3 Hyperimmune Globulin Product Industry Opportunities and Challenges
  4. 2.4 Hyperimmune Globulin Product Industry Restraints
3 Hyperimmune Globulin Product Market by Manufacturers
  1. 3.1 Global Hyperimmune Globulin Product Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hyperimmune Globulin Product Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hyperimmune Globulin Product Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hyperimmune Globulin Product Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hyperimmune Globulin Product Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hyperimmune Globulin Product Manufacturers, Product Type & Application
  7. 3.7 Global Hyperimmune Globulin Product Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hyperimmune Globulin Product Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hyperimmune Globulin Product Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hyperimmune Globulin Product Tier 1, Tier 2, and Tier 3
4 Hyperimmune Globulin Product Market by Type
  1. 4.1 Hyperimmune Globulin Product Type Introduction
  2. 4.1.1 Varicella-Zoster Immune Globulin
  3. 4.1.2 Cytomegalovirus Immune Globulin
  4. 4.1.3 Rho(D) Immune Globulin
  5. 4.1.4 Rabies Immuneglobulins
  6. 4.1.5 Tetanus Toxin Immuneglobulins
  7. 4.1.6 Hepatitis B Immuneglobulins
  8. 4.1.7 Others
  9. 4.2 Global Hyperimmune Globulin Product Sales by Type
  10. 4.2.1 Global Hyperimmune Globulin Product Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Hyperimmune Globulin Product Sales by Type (2021-2032)
  12. 4.2.3 Global Hyperimmune Globulin Product Sales Market Share by Type (2021-2032)
  13. 4.3 Global Hyperimmune Globulin Product Revenue by Type
  14. 4.3.1 Global Hyperimmune Globulin Product Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Hyperimmune Globulin Product Revenue by Type (2021-2032)
  16. 4.3.3 Global Hyperimmune Globulin Product Revenue Market Share by Type (2021-2032)
5 Hyperimmune Globulin Product Market by Application
  1. 5.1 Hyperimmune Globulin Product Application Introduction
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Others
  5. 5.2 Global Hyperimmune Globulin Product Sales by Application
  6. 5.2.1 Global Hyperimmune Globulin Product Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Hyperimmune Globulin Product Sales by Application (2021-2032)
  8. 5.2.3 Global Hyperimmune Globulin Product Sales Market Share by Application (2021-2032)
  9. 5.3 Global Hyperimmune Globulin Product Revenue by Application
  10. 5.3.1 Global Hyperimmune Globulin Product Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Hyperimmune Globulin Product Revenue by Application (2021-2032)
  12. 5.3.3 Global Hyperimmune Globulin Product Revenue Market Share by Application (2021-2032)
6 Global Hyperimmune Globulin Product Sales by Region
  1. 6.1 Global Hyperimmune Globulin Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hyperimmune Globulin Product Sales by Region (2021-2032)
  3. 6.2.1 Global Hyperimmune Globulin Product Sales by Region (2021-2026)
  4. 6.2.2 Global Hyperimmune Globulin Product Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hyperimmune Globulin Product Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hyperimmune Globulin Product Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hyperimmune Globulin Product Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hyperimmune Globulin Product Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hyperimmune Globulin Product Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hyperimmune Globulin Product Revenue by Region
  1. 7.1 Global Hyperimmune Globulin Product Revenue by Region
  2. 7.1.1 Global Hyperimmune Globulin Product Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hyperimmune Globulin Product Revenue by Region (2021-2026)
  4. 7.1.3 Global Hyperimmune Globulin Product Revenue by Region (2027-2032)
  5. 7.1.4 Global Hyperimmune Globulin Product Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hyperimmune Globulin Product Revenue (2021-2032)
  8. 7.2.2 North America Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hyperimmune Globulin Product Revenue (2021-2032)
  11. 7.3.2 Europe Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hyperimmune Globulin Product Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hyperimmune Globulin Product Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hyperimmune Globulin Product Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CNBG
  2. 8.1.1 CNBG Company Information
  3. 8.1.2 CNBG Business Overview
  4. 8.1.3 CNBG Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CNBG Hyperimmune Globulin Product Product Portfolio
  6. 8.1.5 CNBG Recent Developments
  7. 8.2 Sichuan Yuanda Shuyang
  8. 8.2.1 Sichuan Yuanda Shuyang Company Information
  9. 8.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 8.2.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Product Product Portfolio
  12. 8.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 8.3 Shanghai RAAS
  14. 8.3.1 Shanghai RAAS Company Information
  15. 8.3.2 Shanghai RAAS Business Overview
  16. 8.3.3 Shanghai RAAS Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai RAAS Hyperimmune Globulin Product Product Portfolio
  18. 8.3.5 Shanghai RAAS Recent Developments
  19. 8.4 Hualan Bio
  20. 8.4.1 Hualan Bio Company Information
  21. 8.4.2 Hualan Bio Business Overview
  22. 8.4.3 Hualan Bio Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Bio Hyperimmune Globulin Product Product Portfolio
  24. 8.4.5 Hualan Bio Recent Developments
  25. 8.5 CBPO
  26. 8.5.1 CBPO Company Information
  27. 8.5.2 CBPO Business Overview
  28. 8.5.3 CBPO Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CBPO Hyperimmune Globulin Product Product Portfolio
  30. 8.5.5 CBPO Recent Developments
  31. 8.6 Kedrion
  32. 8.6.1 Kedrion Company Information
  33. 8.6.2 Kedrion Business Overview
  34. 8.6.3 Kedrion Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kedrion Hyperimmune Globulin Product Product Portfolio
  36. 8.6.5 Kedrion Recent Developments
  37. 8.7 Kamada
  38. 8.7.1 Kamada Company Information
  39. 8.7.2 Kamada Business Overview
  40. 8.7.3 Kamada Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kamada Hyperimmune Globulin Product Product Portfolio
  42. 8.7.5 Kamada Recent Developments
  43. 8.8 Grifols
  44. 8.8.1 Grifols Company Information
  45. 8.8.2 Grifols Business Overview
  46. 8.8.3 Grifols Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Grifols Hyperimmune Globulin Product Product Portfolio
  48. 8.8.5 Grifols Recent Developments
  49. 8.9 Emergent
  50. 8.9.1 Emergent Company Information
  51. 8.9.2 Emergent Business Overview
  52. 8.9.3 Emergent Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Emergent Hyperimmune Globulin Product Product Portfolio
  54. 8.9.5 Emergent Recent Developments
  55. 8.10 CSL Behring
  56. 8.10.1 CSL Behring Company Information
  57. 8.10.2 CSL Behring Business Overview
  58. 8.10.3 CSL Behring Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CSL Behring Hyperimmune Globulin Product Product Portfolio
  60. 8.10.5 CSL Behring Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Hyperimmune Globulin Product Product Portfolio
  66. 8.11.5 Biotest Recent Developments
  67. 8.12 ADMA Biologics
  68. 8.12.1 ADMA Biologics Company Information
  69. 8.12.2 ADMA Biologics Business Overview
  70. 8.12.3 ADMA Biologics Hyperimmune Globulin Product Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ADMA Biologics Hyperimmune Globulin Product Product Portfolio
  72. 8.12.5 ADMA Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hyperimmune Globulin Product Value Chain Analysis
  2. 9.1.1 Hyperimmune Globulin Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hyperimmune Globulin Product Production Mode & Process
  6. 9.2 Hyperimmune Globulin Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hyperimmune Globulin Product Distributors
  9. 9.2.3 Hyperimmune Globulin Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst